Larvol Delta - Bimekizumab-treatment-in-routine-clinical-care-for-psoriatic-arthritis-Interim-observational-evidence-of-patientreported-outcome-improvements-from-the-European-multicentre-SPEAK-study

Bimzelx (bimekizumab-bkzx) - UCB

https://pagv3.virtual-meeting.org/eadv/eadvcongress2026/en-GB/pag/presentation/64921

Xenofon Baraliakos

Aug 6, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next